ArticleMolecular and clinical oncology2026

A 4-cuproptosis-related lncRNA theragnostic signature predicts survival and immunotherapy response in patients with lung adenocarcinoma.

Lina Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.